<SEC-DOCUMENT>0001144204-17-040142.txt : 20170803
<SEC-HEADER>0001144204-17-040142.hdr.sgml : 20170803
<ACCEPTANCE-DATETIME>20170803093015
ACCESSION NUMBER:		0001144204-17-040142
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20170731
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170803
DATE AS OF CHANGE:		20170803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		171003558

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v472213_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
July 31, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt; text-transform: uppercase">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt; text-transform: uppercase">BIOANALYTICAL
    SYSTEMS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-size: 10pt">(Exact name of registrant as specified in its charter)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Indiana</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0-23357 </FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 30%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">35-1345024</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(State or other jurisdiction of incorporation or organization)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Commission File Number)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2701 KENT AVENUE</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WEST LAFAYETTE, INDIANA</P></TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">47906-1382</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Address of principal executive offices)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Zip Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Registrant's telephone number, including
area code: (765) 463-4527</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act(17CFR240.14a-12)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act(17CFR240.14d-2(b))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act(17CFR240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company&#9;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT><BR CLEAR="ALL"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 31, 2017, Larry
S. Boulet, Chairman of the Board of Directors (the &ldquo;<U>Board</U>&rdquo;) of Bioanalytical Systems, Inc. (the &ldquo;<U>Company</U>&rdquo;),
notified the Company that he was retiring from the Board effective on August 1, 2017. Mr. Boulet served on the Board for over 10
years and the Company is deeply grateful to him for his exemplary leadership and personal dedication to the Company and its shareholders.
In connection with his retirement from the Board, Mr. Boulet also retired from his positions on the Board&rsquo;s committees and
as Chairman of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 1, 2017,
the Board unanimously elected R. Matthew Neff as an independent, Class I director and appointed Mr. Neff as Chairman of the Company&rsquo;s
Audit Committee. Mr. Neff&rsquo;s term will expire at the 2019 annual meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a director of the
Company, Mr. Neff will receive compensation as a non-employee director in accordance with the Company&rsquo;s non-employee director
compensation practices described in the Company&rsquo;s Proxy Statement on Schedule 14A filed with the Securities and Exchange
Commission on January 30, 2017. This compensation generally consists of cash payments (annual cash retainers and Board and committee
meeting fees) and such stock option awards as may be granted from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A copy of the press
release announcing the election of Mr. Neff is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 7.01 Regulation FD Disclosure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with Mr. Boulet&rsquo;s retirement,
the Board unanimously elected Gregory C. Davis, Ph.D. as interim Chairman of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01 Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Exhibits:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">99.1</TD><TD>Press Release dated August 3, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase">Bioanalytical
Systems, Inc. </FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: August 3, 2017&#9;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Jill C. Blumhoff</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Jill C. Blumhoff<BR>Chief Financial Officer,</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">Vice President&mdash;Finance</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.8in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.8in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit Index</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B><U>Exhibit No.</U></B></TD><TD STYLE="text-align: justify"><B><U>Description</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">99.1</TD><TD>Press Release dated August 3, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.8in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.8in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v472213_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%"><IMG SRC="image_001.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: right; vertical-align: bottom"><P STYLE="margin: 0pt 0"><FONT STYLE="font-size: 16pt">NEWS
                                         RELEASE</FONT></P>


</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: right"><B>FOR MORE INFORMATION: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Contact:</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; background-color: white; text-indent: 0.75in"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">Jill Blumhoff</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">Chief Financial
Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">&amp; Vice President&mdash;Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">Phone: 765.497.8381</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><U>jblumhoff@BASInc.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-size: 14pt"><B>BASi
Announces Election of R. Matthew Neff to the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>WEST
LAFAYETTE, INDIANA</B> &ndash;August 3, 2017 &ndash; <B>Bioanalytical Systems, Inc. (NASDAQ: BASI) (&ldquo;BASi&rdquo; or the &ldquo;Company&rdquo;)</B>
today announced that its Board of Directors unanimously elected R. Matthew Neff, as a director, effective August 1, 2017. &quot;We
are pleased to welcome Mr. Neff to the Board and look forward to working with him. His strong management, financial and legal background
will be important, as we continue to focus on driving value for our shareholders. Mr. Neff fills the vacancy on the Board created
by Larry Boulet&rsquo;s retirement, and we want to thank Mr. Boulet for over 10 years of exemplary leadership and personal dedication
to the Company,&quot; interim Chairman Dr. Greg Davis said. The Board of Directors also appointed Mr. Neff as Chairman of the Audit
Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Mr.
Neff is currently Of Counsel with Bingham Greenebaum Doll LLP&rsquo;s Corporate and Transactional Department. From August 2013
through June 2016, Mr. Neff served as Chairman, President and Chief Executive Officer of AIT Laboratories, a national toxicology
lab headquartered in Indianapolis, Indiana. Mr. Neff joined AIT Laboratories after his tenure as President and Chief Executive
Officer of CHV Capital, Inc., the venture capital subsidiary of Indiana University Health, a role he had held since 2007.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Mr.
Neff started his career as a practicing lawyer and Partner at Baker &amp; Daniels. He then served as the Deputy to the Chairman
of the Federal Housing Finance Board (now known as the Federal Housing Finance Agency) in the first Bush Administration. Thereafter,
he became the co-founder and Chief Executive Officer of two Indianapolis companies: Circle Investors, an insurance holding company
then chaired by former Vice President of the United States, Dan Quayle, and Senex Financial Corp., a healthcare receivables finance
company. Mr. Neff currently serves on the Board of Directors of Fairbanks Addiction Treatment Center and was a member of Riley
Children&rsquo;s Foundation&rsquo;s Board of Directors from January 2000 to November 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Mr.
Neff earned his bachelor&rsquo;s degree and graduated a Phi Beta Kappa from DePauw University. He also received his Juris Doctor
degree from Indiana University School of Law, where he was the Executive Editor of the Indiana Law Review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>About Bioanalytical
Systems, Inc. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">BASi
is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading
drug development companies and medical research organizations. The company focuses on developing innovative services and products
that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASinc.com for more information about BASi.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>This release
may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties
related to changes in the market and demand for our products and services, the development, marketing and sales of products and
services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in
the company's filings with the Securities and Exchange Commission.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I><IMG SRC="image_002.jpg" ALT="">&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>&nbsp;</I></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I></I></P>



<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 0H# 2(  A$! Q$!_\0
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M^=J*>['_ #FO,KO5+V^F,MQ<.Y)S@G@?0=J[OQK;M-H8D7)\F4,WTP1_,BN
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M??V-=YI?B;3]4VH'\F<_\LY#U^A[UC@,3AITE2:2?9]3;'X;$PJNJFVNZZ&
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I[#GD_P"S[T^[_MHW<:1R3!5$$3NB#:S$YD?Z #'U-=%10 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" G # 2(  A$! Q$!_\0
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M1?B%CN/[1LO^?J'_ +[%']HV7_/U#_WV*X?FCFC_ %@J_P B_$+'<?VC9?\
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M9X+8VD:LH5HRTH#;O?.-H)'6KMW'*W@P1JC&;[*@"[3G.!VZT?5Z/\B^Y?Y
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M9/X&J^I:;)>7MG-&Z*D;8G#?QID, /\ @2K^&:S)?#=RUN4$J,5N=Z)N*@Q
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
F4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
